Study # 2016-0046

Multicenter trial for eliminating breast cancer surgery or radiotherapy in exceptional responders to neoadjuvant systemic therapy

Study Status:

Enrolling

Treatment Agent:

Radiation, Surgery

Description

Short Title: Exceptional Responders

This clinical trial studies eliminating surgery and how well radiation therapy after systemic therapy works in treating patients with HER2 positive or triple negative breast cancer when image-guided biopsy shows no residual cancer. Patients then receive standard breast radiotherapy.

Resources and Links

National Clinical Trial Identified Number: NCT02945579

Information and next steps

Disease:

  • Breast Cancer,
  • Estrogen Receptor Negative,
  • HER2 Positive Breast Carcinoma,
  • HER2/Neu Negative,
  • Invasive Breast Carcinoma,
  • Progesterone Receptor Negative,
  • Triple-Negative Breast Carcinoma,
  • Stage 1A, 1B, II, IIA, IIB

Study Phase:

Not applicable

Physician Name:

Ask a Question